

Obesity and Weight Loss with Endocrinologist Rocio Salas-Whalen
9 snips Sep 23, 2022
Dr. Rocio Salas-Whalen, owner of New York Endocrinology and a renowned expert in diabetes and obesity, dives into the evolving understanding of obesity as a chronic disease. She discusses its complex ties to type 2 diabetes and the rising awareness post-COVID-19. The conversation highlights groundbreaking GLP-1 and GIP medications that reshape the weight loss landscape, discussing their benefits and psychological impacts on food cravings. Dr. Salas-Whalen also addresses the challenges posed by insurance companies in treating obesity, pushing for a more proactive medical approach.
AI Snips
Chapters
Transcript
Episode notes
Obesity Reclassified
- Obesity has been reclassified as a chronic metabolic and multifactorial disease.
- It's not simply a lifestyle problem of eating less and exercising more.
COVID-19 and Obesity
- COVID-19 highlighted the severity of obesity as a health risk.
- Patients with obesity experienced higher rates of severe illness, ICU admissions, and mortality.
Patient History
- Dr. Salas-Whalen asks patients how young they were when they first remember having a weight issue.
- Grown men have cried in her appointments due to the emotional toll of weight struggles.